Ondansetron Injection
Product Images NDC 68083-114

2 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68083-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron-spl-structure (Ondansetron Spl Structure)

Ondansetron-spl-structure (Ondansetron Spl Structure)
Chemical structure of Ondansetron hydrochloride dihydrate, depicted with its molecular formula highlighting the key heterocyclic rings and functional groups.*
FDA Label Image

Ondansetron-spl-carton-20ml (Ondansetron Spl Carton 20ml)

Ondansetron-spl-carton-20ml (Ondansetron Spl Carton 20ml)
Ondansetron Injection USP 2 mg/mL (40 mg/20 mL) multidose vial label from Gland Pharma Limited. The label includes drug identification, strength, dosage form for intravenous or intramuscular injection, storage instructions, preservative details, and space for lot number and expiration date. The vial is sterile and Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.